Designing drug regimens that mitigate nonadherence

DOI10.1007/S11538-021-00976-3zbMath1484.92038arXiv2108.08358OpenAlexW4205272981WikidataQ113900093 ScholiaQ113900093MaRDI QIDQ2079020

Sean D. Lawley, Elijah D. Counterman

Publication date: 4 March 2022

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://arxiv.org/abs/2108.08358

Mathematics Subject Classification ID

Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)

Related Items (2)

Statistical analysis of two-compartment pharmacokinetic models with drug non-adherence ⋮ Understanding and Quantifying Network Robustness to Stochastic Inputs

Uses Software

• Unnamed Item

Cites Work

• Variability and singularity arising from poor compliance in a pharmacokinetic model. II: The multi-oral case
• Spectral property of the Bernoulli convolutions
• Moments of infinite convolutions of symmetric Bernoulli distributions
• On the random series \(\sum\pm\lambda^ n\) (an Erdös problem)
• Ergodicity of 2D Navier-Stokes equations with random forcing and large viscosity
• Stochastic Switching in Infinite Dimensions with Applications to Random Parabolic PDE
• Random Point Attractors Versus Random Set Attractors
• Self-similar measures and intersections of Cantor sets
• Markov Chains
• Probability
• Electrodiffusive Flux Through a Stochastically Gated Ion Channel
• Distribution Functions and the Riemann Zeta Function
• Unnamed Item
• Unnamed Item

This page was built for publication: Designing drug regimens that mitigate nonadherence